Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626755 · ClinicalTrials.gov registry record · NA
Prevention of Phantom Limb Pain After Transtibial Amputation
A NA study, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01626755 is a NA study that was terminated before completion, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The registered enrollment target is 12 participants.
The verdict
NCT01626755, a NA study, was terminated before completion, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Phantom limb pain following amputation is a major problem. Current evidence how to best prevent phantom limb pain is equivocal because previous trials have included small numbers of patients, and tested heterogeneous patient collectives. There is some evidence that optimized perioperative pain control is effective in preventing phantom limb pain, but the potential added role of regional anesthesia has not been defined. Objective: The Aim of this study is to test the hypothesis that sciatic nerve block decreases the point prevalence of phantom limb pain 12 months after transtibial amputation for peripheral vascular disease compared to optimized intravenous pain therapy. Study design: Randomized, prospective, double-blind (patient, physician, statistician) clinical trial. All patients will receive standard optimized intravenous anesthesia and analgesia (opiate patient-controlled analgesia (PCA), intravenous ketamine). Patients in the intervention group will receive additional infusion of local anesthetic via a sciatic nerve catheter placed under ultrasound guidance. Main outcome of this study: Point prevalence of chronic phantom limb pain after 12 months.
Interventions
- PROCEDURE Sciatic name block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626755
The ClinicalTrials.gov registry entry for NCT01626755 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sciatic name block is the first listed.
NCT01626755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626755 about?
NCT01626755 is a clinical study titled "Prevention of Phantom Limb Pain After Transtibial Amputation". Phantom limb pain following amputation is a major problem. Current evidence how to best prevent phantom limb pain is equivocal because previous trials have included small numbers of patients, and tested heterogeneous patient collectives. There is some evidence that optimized perioperative pain contr...
What is the current status of trial NCT01626755?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2013-08. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01626755?
The interventions under investigation include: Sciatic name block (PROCEDURE).
Who is sponsoring clinical trial NCT01626755?
This trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.